fluorobenzenes has been researched along with Nephrotic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bovy, C; Grosch, S; Krzesinski, JM; Van Overmeire, L | 1 |
| Kim, CH; Kim, S; Vaziri, ND | 1 |
2 other study(ies) available for fluorobenzenes and Nephrotic Syndrome
| Article | Year |
|---|---|
[Fibrillary nonamyloid glomerulonephritis: a rare etiology of nephrotic syndrome].
Topics: Coloring Agents; Complement C3; Congo Red; Diagnosis, Differential; Edema; Female; Fluorobenzenes; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Hypercholesterolemia; Immunoglobulin G; Kidney Glomerulus; Losartan; Microscopy, Electron; Middle Aged; Nephrotic Syndrome; Prednisolone; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2011 |
Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy.
Topics: Animals; Blotting, Western; Cholesterol; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; LDL-Receptor Related Protein-Associated Protein; Liver; Male; Nephrotic Syndrome; Pyrimidines; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA; Rosuvastatin Calcium; Sulfonamides; Triglycerides; Up-Regulation | 2005 |